FDA Inspection 1232054 — Joshua Samuel Jacobs, M.D.
The FDA completed an inspection of Joshua Samuel Jacobs, M.D. on Jan 26, 2024 in Walnut Creek, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Jan 26, 2024
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Walnut Creek, CA (United States)
Additional details
Clinical Investigator (CI)